|Bid||33.22 x 9600|
|Ask||33.23 x 4800|
|Day's Range||33.17 - 33.48|
|52 Week Range||29.83 - 37.39|
|PE Ratio (TTM)||27.96|
|Dividend & Yield||1.28 (3.82%)|
|1y Target Est||N/A|
In 2016, Pfizer’s (PFE) Sutent reported revenues of ~$1.1 billion, which represented a ~2% decline on a YoY (year-over-year) basis.
In 2016, Pfizer’s (PFE) Prevnar 13 reported revenues of ~$5.7 billion, which reflected a ~8% decline on a YoY (year-over-year) basis.
In 2016, Pfizer’s (PFE) Xeljanz reported revenues of ~$927 million, which reflected a ~77% growth YoY (year-over-year).